Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin- induced diabetes

Shiyun Zhang, Qianqian Dai, Bin Zhang, Siyang Liu, Ying Wang, Yixue Zhang, Dongyue Chen, Ningning Zong, Hongwei Wang, Jingjing Ding, Qian Gao, Yanting WenAnnals 2021 · DOI

Abstract

These results may reveal important connections for PI3K/Akt inhibition and Tregs' homeostasis in T1D after transplantation. AHSCT combining immunoregulatory strategies such as PI3K inhibition may be a promising therapeutic approach in later-stage T1D.
BibTeX
@article{zhang2021syngeneic,
  author = {Shiyun Zhang and Qianqian Dai and Bin Zhang and Siyang Liu and Ying Wang and Yixue Zhang and Dongyue Chen and Ningning Zong and Hongwei Wang and Jingjing Ding and Qian Gao and Yanting Wen},
  title = {{Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin- induced diabetes}},
  journal = {Annals},
  year = {2021},
  doi = {10.21037/atm-21-3329},
}

Loading related content...

Figure